MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Prevalence of Transcobalamin Receptor Antibodies and Relationships with Vitamin B12 and Holotranscobalamin in Parkinson’s Disease

    C. Christine, J. Pluvinage, P. Auinger, E. Forti, L. Tat, R. Green, M. Wilson (San Francisco, USA)

  • Prevalence of urinary problems in men and women with Parkinson’s disease. A study from the Mexican Parkinson’s Research Network.

    A. Garcia, A. Fierro, A. Solari, P. Reyes, A. Lazaro, E. Morelos, C. Guerra, I. Estrada, K. Salinas, Y. Matuk, N. Gandarilla, U. Caballero, P. Montés, V. Flores, I. Espinosa, A. Hayas, E. Gaspar, D. Vazquez, M. Rodriguez, E. Waldo, T. Leal, M. Inca, I. Mata, S. Alcauter, M. Renteria, A. Medina, A. Ruiz (CDMX, Mexico)

  • Prevalence, demographic characteristics of Parkinson disease and associated comorbidities: An analysis of the Colombian Ministry of Health official registry

    A. Rincon, C. Pantoja, J. Torres, C. Tamayo, D. Rosselli (Bogotá, Colombia)

  • Privacy and Personalisation: Predicting Parkinson’s Severity with Federated Learning

    C. Hinchliffe, H. Hiden, E. Packer, P. Brown, A. Yarnell, L. Rochester, L. Alcock, M. Peeters, S. Del Din, P. Watson (Newcastle upon Tyne, United Kingdom)

  • Proactive Brain Health Alliance Serving Those at Risk for Neurodegenerative Disease

    A. Mitchell, P. Mahant, S. Winter, K. Merkel (Phoenix, USA)

  • Probing Social Cognition and Emotional Facial Expression Recognition in Cervical Dystonia through Integration of EEG and Eye-Tracking

    D. Diez Clarke, V. Georgiadou, C. O'Keeffe, J. Inocentes, A. Gallagher, S. Rafee, O. Killian, L. Williams, S. O'Riordan, M. Hutchinson, R. Reilly, C. Fearon (Dublin, Ireland)

  • Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson’s Disease – A Randomized, Placebo-Controlled Trial (Short Title: ProD)

    A. Lemkow, A. Kuan, J. Lam, F. Vila-Rodriguez, M. Mckeown, J. Squires, A. Howard, S. Appel-Cresswell (Vancouver, Canada)

  • Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents

    WZ. Hu, Q. Yang, Y. Huang (Guangzhou, China)

  • Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease

    D. Weintraub (Philadelphia, USA)

  • Prodromal Parkinson’s Disease in Agent Orange Exposed US Vietnam Veterans

    E. Uc, C. Weber, M. Lenz, J. Dawson (Iowa City, USA)

  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley